Niagen Bioscience, Inc. NAGE
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2007-06-25
Niagen Bioscience, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 3,116,178 | $8.5M |
| RENAISSANCE TECHNOLOGIES LLC | 1,328,843 | $5.9M |
| AQR CAPITAL MANAGEMENT LLC | 1,031,335 | $4.5M |
| CITADEL ADVISORS LLC | 678,277 | $3.0M |
| MILLENNIUM MANAGEMENT LLC | 551,349 | $2.4M |
| D. E. Shaw & Co., Inc. | 277,381 | $1.2M |
Source: SEC EDGAR filings · CIK 0001386570 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.